Here's What Key Metrics Tell Us About Sally Beauty (SBH) Q4 Earnings
Werte in diesem Artikel
For the quarter ended September 2025, Sally Beauty (SBH) reported revenue of $947.08 million, up 1.3% over the same period last year. EPS came in at $0.55, compared to $0.50 in the year-ago quarter.The reported revenue represents a surprise of +1.51% over the Zacks Consensus Estimate of $933 million. With the consensus EPS estimate being $0.49, the EPS surprise was +12.24%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Sally Beauty performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Comparable sales growth - Sally Beauty Supply: 1.2% versus the two-analyst average estimate of -0.7%.Comparable sales growth - Beauty Systems Group: 1.4% versus 1% estimated by two analysts on average.Number of stores at end-of-period - Beauty Systems Group: 1,326 compared to the 1,329 average estimate based on two analysts.Number of stores at end-of-period - Total: 4,422 versus the two-analyst average estimate of 4,425.Number of stores at end-of-period - Sally Beauty Supply: 3,096 versus 3,096 estimated by two analysts on average.Comparable sales growth - Consolidated: 1.3% versus the two-analyst average estimate of 0%.Net Sales- Sally Beauty Supply: $541.56 million versus $527.69 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +1.4% change.Net Sales- Beauty Systems Group: $405.52 million versus the two-analyst average estimate of $405.31 million. The reported number represents a year-over-year change of +1.1%.View all Key Company Metrics for Sally Beauty here>>>Shares of Sally Beauty have returned -1.4% over the past month versus the Zacks S&P 500 composite's +4.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.#1 Semiconductor Stock to Buy (Not NVDA)The incredible demand for data is fueling the market's next digital gold rush. As data centers continue to be built and constantly upgraded, the companies that provide the hardware for these behemoths will become the NVIDIAs of tomorrow.One under-the-radar chipmaker is uniquely positioned to take advantage of the next growth stage of this market. It specializes in semiconductor products that titans like NVIDIA don't build. It's just beginning to enter the spotlight, which is exactly where you want to be.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Sally Beauty Holdings, Inc. (SBH): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Sally Beauty und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Q4
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Q4
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: Zacks
Nachrichten zu Q4 Inc Registered Shs Unitary
Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar.
Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv
Analysen zu Q4 Inc Registered Shs Unitary
Keine Analysen gefunden.